Glenmark Pharmaceuticals Limited (BOM:532296)
India · Delayed Price · Currency is INR 2,407.75
+32.95 (1.39%)
At close: Sep 16, 2026
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 669.3 billion as of September 16, 2026. Its market cap has increased by 12.96% in one year.
Market Cap
669.30B
Enterprise Value
663.47B
Revenue
177.37B
Ranking
n/a
PE Ratio
37.23
Stock Price
2,407.75
ChartMarket Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 669.30B, an increase of 58,134.91%. That is a compound annual growth rate of 28.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 669.30B | 16.53% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.84T |
| Dr. Reddy's Laboratories | 957.72B |
| Lupin | 939.78B |
| Abbott India | 555.53B |
| GlaxoSmithKline Pharmaceuticals | 480.64B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 216.20B |
| Caplin Point Laboratories | 209.39B |